Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers
The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
Decreased dopaminergic function has been postulated to underlie cocaine addiction. To examine the possibility that dysfunction of brain regions subserved by the dopamine system could promote cocaine self‐administration, positron emission tomography and a dual‐tracer approach was used to examine dopamine D 2 receptor availability and regional brain glucose metabolism in cocaine abusers. When compared to normal controls, cocaine abusers showed significant decreases in dopamine D 2 receptor availability which persisted 3‐4 months after detoxification. Decreases in dopamine D 2 receptor availability were associated with decreased metabolism in several regions of the frontal of these brain areas which are involved in the channeling of drive and affect could lead to loss of control resulting in compulsive drug‐taking behavior. © 1993 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These low levels of striatal D2 receptors have been associated with decreases in baseline glucose metabolism (ie, a marker of brain function) in the prefrontal cortex (including dorsolateral prefrontal cortex, anterior cingulate gyrus, and medial orbitofrontal cortex),35,123,124 impulsivity in methamphetamine abusers,125 and compulsive cocaine administration in rodents.15”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [123]
In the citing paper
“There are multiple lines of evidence that cocaine dependence is associated with a decrease in D2 receptor binding [164-167], a pattern that seems to persist after disease remission [165].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [165]
In the citing paper
“On the other hand, the decrease in D2 receptor binding is long lasting, at least 3–4 months in humans (Volkow et al., 1993) and possibly longer, up to a year in non-human primates depending on the individual (Nader et al., 2006).”
From Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (2014) · cites this paper as Volkow et al., 1993
In the citing paper
“Imaging studies of cocaine and methamphetamine abuse have shown that low D2 receptor binding in the striatum is associated with reduced glucose metabolism in the prefrontal cortex, including the orbito-frontal cortex and cingulate gyrus, which play a key role in impulsivity (Volkow et al., 2001a; Volkow et al., 1993).”
From Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (2014) · cites this paper as Volkow et al., 1993
In the citing paper
“In humans addicted to drugs, the reduction in striatal D2R is associated with decreased activity of prefrontal regions, OFC, anterior cingulate gyrus (ACC) and dorsolateral prefrontal cortex (DLPFC) (67,74,75).”
From Obesity and addiction: Neurobiological overlaps (2013) · cites this paper as [74]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Stuss, D. T., & Benson, D. F. (1986) · Raven Press eBooks · Cited by 2,637
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Le Moal, M., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,093
Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey
Selemon, L., & Goldman-Rakic, P. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-03-00776.1985 · Cited by 1,073
Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity
Oades, R. D., & Halliday, G. M. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90011-7 · Cited by 1,008
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Research works printed but not linked: 11
- Baxter L. R., 1988, Localization of neurochemical effects of cocaine and other stimulants, J. Clin. Psychiatry, 49, 23
- Fallon J. H., 1987, Cerebral Cortex, 41
- Hegarty A., 1990, Cocaine as a risk factor for acute dystonic reaction (abstract), Neurology, 40, 146
- Heimer L., 1985, The Rat Nervous System, 37
- Hitzemann R. Burr G. Piscani K. Hazan J. Krishnamoorthy G. Cushman P. Baldwin C. H. Carrion R. Volkow N. D. Hirschowitz J. Handelsman L. Chiaramonte J. andAngrist B.Neuroendocrine and clinical features of cocaine withdrawal.Psychiatry Res.(in press).
- Hoff A., 1991, Cognitive function in chronic cocaine abusers, J. Clin. Exp. Neuropsychol., 13, 60
- Matsui T., 1979, Anatomy of the Human Brain for Computerized Tomography
- Rinne U. K., 1990, Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 53, 177
- Volkow N. D., 1992, Distribution of C‐11 cocaine in human heart, lungs liver and adrenal. A dynamic PET study, J. Nucl. Med., 33, 521
- Wilson R. J., 1990, Markedly reduced striatal dopamine levels in brain of a chronic cocaine abuser, Soc. Neurosci. Abstr., 16, 252
- Wise R. A., 1990, Cocaine in the Brain, 42
Cited by
Items 401–500 of 943
Thomsen, G., Ziebell, M., Jensen, P. S., da Cunha‐Bang, S., Knudsen, G. M., & Pinborg, L. H. (2013) · Obesity · doi:10.1002/oby.20225 · Cited by 43
Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction
Hadad, N. A., & Knackstedt, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3461-1 · Cited by 38
Brown, A. L., Flynn, J. R., Smith, D. W., & Dayas, C. V. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001367 · Cited by 40
Neurocognition as a Moderator and Mediator in Adolescent Substance Misuse Prevention
Riggs, N. R., & Greenberg, M. T. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990903005940 · Cited by 43
Wiers, C. E., Shokri-Kojori, E., Cabrera, E., Cunningham, S., Wong, C., Tomasi, D., Wang, G.-J., & Volkow, N. D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.056 · Cited by 41
Self-citationOlière, S., Joliette-Riopel, A., Potvin, S., & Jutras‐Aswad, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00109 · Cited by 47
Dobbs, L. K., Kaplan, A. R., Bock, R., Phamluong, K., Shin, J. H., Bocarsly, M. E., Eberhart, L., Ron, D., & Alvarez, V. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0286-3 · Cited by 42
Imaging Receptor Changes in Human Drug Abusers
Cosgrove, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_24 · Cited by 45
Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers
Wiers, C. E., Shumay, E., Cabrera, E., Kojori, E. S., Gladwin, T. E., Skarda, E., Cunningham, S. I., Kim, S. W., Wong, T. C., Tomasi, D. G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.14 · Cited by 43
Self-citationMclntyre, R. S., Nguyen, H. T., Soczynska, J. K., Lourenco, M. T. C., Woldeyohannes, H. O., & Konarski, J. Z. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/rsmcintyre · Cited by 40
Reinforcement learning detuned in addiction: integrative and translational approaches
Groman, S. M., Thompson, S. L., Lee, D., & Taylor, J. R. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.11.007 · Cited by 42
Drugs currently in Phase II clinical trials for cocaine addiction
Kim, J. H., & Lawrence, A. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.915312 · Cited by 43
Dobbs, L. K., Lemos, J. C., & Alvarez, V. A. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12361 · Cited by 41
Cocaine withdrawal and neuro-adaptations in ion channel function
Hu, X. (2007) · Molecular Neurobiology · doi:10.1007/bf02700626 · Cited by 42
Gould, R. W., Duke, A. N., & Nader, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.004 · Cited by 42
Cocaine, Hormones, and Behavior: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00098-x · Cited by 39
Individual differences in latent neuropsychological abilities at addictions treatment entry.
Bates, M. E., Labouvie, E. W., & Voelbel, G. T. (2002) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.16.1.35 · Cited by 42
Adinoff, B. H., Williams, M. J., Best, S. E., Harris, T. S., Chandler, P. A., & Devous, M. D. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80209-3 · Cited by 41
Implications from addiction research towards the understanding and treatment of obesity
Grosshans, M., Loeber, S., & Kiefer, F. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00300.x · Cited by 44
Addiction and imaging of the living human brain
Gatley, S. J., & Volkow, N. D. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00069-6 · Cited by 42
Self-citationCrunelle, C. L., Veltman, D. J., Booij, J., Oortmerssen, K. V. E., & van den Brink, W. (2012) · Brain and Behavior · doi:10.1002/brb3.65 · Cited by 42
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation
Seger, D. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516263 · Cited by 43
Sweitzer, M. M., Geier, C. F., Denlinger, R. L., Forbes, E. E., Raiff, B. R., Dallery, J., McClernon, F. J., & Donny, E. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4152-2 · Cited by 37
Yamamoto, D. J., Woo, C., Wager, T. D., Regner, M. F., & Tanabe, J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.026 · Cited by 38
Bruijnzeel, A. W., Alexander, J. C., Pérez, P. D., Bauzo-Rodriguez, R., Hall, G., Klausner, R., Guerra, V. M. C. D. O., Zeng, H., Igari, M., & Febo, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu011 · Cited by 41
Utility of Nonhuman Primates in Substance Use Disorders Research
Banks, M. L., Czoty, P. W., & Negus, S. S. (2017) · ILAR Journal · doi:10.1093/ilar/ilx014 · Cited by 39
Cognitive Performance by Humans During a Smoked Cocaine Binge-Abstinence Cycle
Pace-Schott, E. F., Stickgold, R., Muzur, A., Wigren, P. E., Ward, A. S., Hart, C. L., Walker, M., Edgar, C., & Hobson, J. A. (2005) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-200068120 · Cited by 36
The effects of benzamide analogues on cocaine self-administration in rhesus monkeys
Nader, M. A., Green-Jordan, K., Luedtke, R. R., & Mach, R. H. (1999) · Psychopharmacology · doi:10.1007/s002130051154 · Cited by 36
Pina, M. M., & Cunningham, C. L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3252-0 · Cited by 39
Urban, N., & Martínez, D. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.011 · Cited by 36
Outcomes of deep brain stimulation surgery for substance use disorder: a systematic review
Hassan, O., Phan, S., Wiecks, N., Joaquin, C., & Bondarenko, V. (2020) · Neurosurgical Review · doi:10.1007/s10143-020-01415-y · Cited by 38
Hutsell, B. A., Cheng, K., Rice, K. C., Negus, S. S., & Banks, M. L. (2015) · Addiction Biology · doi:10.1111/adb.12206 · Cited by 40
Blunted responses to stress and reward: Reflections on biological disengagement?
Ginty, A. T. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2013.06.008 · Cited by 39
Proton Magnetic Resonance Spectroscopy in Alcohol Use Disorders: A Potential New Endophenotype?
Meyerhoff, D. J., & Durazzo, T. C. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00695.x · Cited by 37
Trifilieff, P., & Martínez, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00044 · Cited by 41
Reid, A. G., Lingford-Hughes, A. R., Cancela, L. M., & Kalivas, P. W. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00024-3 · Cited by 36
WENZEL, K., BERNSTEIN, D. P., HANDELSMAN, L., RINALDI, P., RUGGIERO, J., & HIGGINS, B. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199604000-00004 · Cited by 35
Dopamine Receptor Subtypes in Reward and Relapse
Self, D. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_17 · Cited by 40
Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults
Wilens, T. E., Prince, J. B., Biederman, J., Spencer, T. J., & Frances, R. J. (1995) · Psychiatric Services · doi:10.1176/ps.46.8.761 · Cited by 35
The Speed of Cocaine Delivery Determines the Subsequent Motivation to Self-Administer the Drug
Minogianis, E.-A., Lévesque, D., & Samaha, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.173 · Cited by 36
Addiction: A dysregulation of satiety and inflammatory processes
Harricharan, R., Abboussi, O., & Daniels, W. M. U. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2017.07.012 · Cited by 38
Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
Foll, B. L., Payer, D. E., Ciano, P. D., Guranda, M., Nakajima, S., Tong, J., Mansouri, E., Wilson, A. A., Houle, S., Meyer, J., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.177 · Cited by 34
Contributions of neuroimaging to understanding sex differences in cocaine abuse.
Andersen, M. L., Sawyer, E. K., & Howell, L. L. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025219 · Cited by 34
Social Reward Dependence and Brain White Matter Microstructure
Bjørnebekk, A., Westlye, L. T., Fjell, A. M., Grydeland, H., & Walhovd, K. B. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr345 · Cited by 35
Dissecting Impulsivity: Brain Mechanisms and Neuropsychiatric Implications
Robbins, T. W., & Dalley, J. W. (2017) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-51721-6_7 · Cited by 37
Kreek, M. J., Schlussman, S. D., Bart, G. B., LaForge, K. S., & Butelman, E. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.024 · Cited by 36
Pérez-Mañá, C., Castells, X., Vidal, X., Casas, M., & Capellà, D. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.08.012 · Cited by 33
Neurobiology of Learning and Memory
Volkow, N. D., Fowler, J. S., Wang, G., & Goldstein, R. Z. (2002) · Cited by 33
Self-citationAttenuated behavioural responses to acute and chronic cocaine in GASP‐1‐deficient mice
Boeuf, J., Trigo, J. M., Moreau, P., Lecourtier, L., Vogel, E., Cassel, J., Mathis, C., Klosen, P., Maldonado, R. J., & Simonin, F. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06865.x · Cited by 33
Zhukovsky, P., Puaud, M., Jupp, B., Sala‐Bayo, J., Alsiö, J., Xia, J., Searle, L. R., Morris, Z., Sabir, A., Giuliano, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0381-0 · Cited by 34
Hou, H., Wang, C., Jia, S., Hu, S., & Tian, M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-014-1469-5 · Cited by 36
Neuroscience of resilience and vulnerability for addiction medicine
Morrow, J. D., & Flagel, S. B. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.09.004 · Cited by 34
Hanlon, C. A., Dowdle, L. T., & Jones, J. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.006 · Cited by 36
Desfossés, J., Stip, É., Bentaleb, L. A., Lipp, O., Chiasson, J., Fürtös, A., Venne, K., Kouassi, É., & Potvin, S. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00085 · Cited by 32
Therapeutic doses of buspirone block D3 receptors in the living primate brain
Kim, S. W., Fowler, J. S., Skolnick, P., Muench, L., Kang, Y., Shea, C. E., Logan, J., Kim, D., Carter, P., King, P. T., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000194 · Cited by 32
Self-citationDu, C., Volkow, N. D., You, J., Park, K., Allen, C. P., Koob, G. F., & Pan, Y. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0261-8 · Cited by 40
Self-citationJerlhag, E. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.11.004 · Cited by 36
Nonhuman Primate Neuroimaging and the Neurobiology of Psychostimulant Addiction
Howell, L. L., & Murnane, K. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.023 · Cited by 32
Cates, H. M., Li, X., Purushothaman, I., Kennedy, P., Shen, L., Shaham, Y., & Nestler, E. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0158-x · Cited by 33
PET Imaging Studies in Drug Abuse
Fowler, J. S., & Volkow, N. D. (1998) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659809028936 · Cited by 35
Self-citationKoob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 42
Self-citationLim, T. V., Cardinal, R. N., Savulich, G., Jones, P. S., Moustafa, A. A., Robbins, T. W., & Ersche, K. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05330-z · Cited by 36
Medications and Substances as a Cause of Headache: A Systematic Review of the Literature
Toth, C. C. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200305000-00005 · Cited by 31
Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Klausen, M. K., Knudsen, G. M., Vilsbøll, T., & Fink‐Jensen, A. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70004 · Cited by 35
Narendran, R., Martínez, D., Mason, N. S., Lopresti, B. J., Himes, M. L., Chen, C., May, M. A., Price, J. C., Mathis, C. A., & Frankle, W. G. (2011) · Synapse · doi:10.1002/syn.20970 · Cited by 32
Chronic cocaine disrupts mesocortical learning mechanisms
Buchta, W. C., & Riegel, A. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.003 · Cited by 34
García‐García, I., Zeighami, Y., & Dagher, A. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0755-9 · Cited by 33
Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review
Tardelli, V. S., do Lago, M. P. P., Mendez, M., Bisaga, A. M., & Fidalgo, T. M. (2018) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.10.002 · Cited by 30
Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions
Volkow, N. D., Wang, G., Fowler, J. S., Franceschi, D., Thanos, P. K., Wong, C., Gatley, S. J., Ding, Y., Molina, P. E., Schlyer, D. J., et al. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00421-5 · Cited by 36
Self-citationPergolide Mesylate for Cocaine Abuse: A Controlled Preliminary Trial
LEVIN, F. R., McDowell, D. M., Evans, S. M., Brooks, D. J., Spano, C., & Nunes, E. V. (1999) · American Journal on Addictions · doi:10.1080/105504999305929 · Cited by 30
Disrupted Resting-State Default Mode Network in Betel Quid-Dependent Individuals
Zhu, X., Zhu, Q., Jiang, C., Shen, H., Wang, F., Liao, W., & Yuan, F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00084 · Cited by 30
The use of brain imaging to elucidate neural circuit changes in cocaine addiction
Hanlon, C. A., & Canterberry (2012) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s35153 · Cited by 34
Peoples, L. L., Kravitz, A. V., Lynch, K. G., & Cavanaugh, D. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301203 · Cited by 30
Yip, S. W., & Potenza, M. N. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.003 · Cited by 32
Kim, M., Custodio, R. J. P., Botanas, C. J., de la Peña, J. B., Sayson, L. V., Abiero, A., Ryoo, Z. Y., Cheong, J. H., & Kim, H. J. (2018) · Addiction Biology · doi:10.1111/adb.12663 · Cited by 30
Nonhuman Primate Models of Addiction and PET Imaging: Dopamine System Dysregulation
Gould, R. W., Porrino, L. J., & Nader, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_168 · Cited by 33
Nader, M. A., Grant, K. A., Gage, H. D., Ehrenkaufer, R. L., Kaplan, J. R., & Mach, R. H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00101-8 · Cited by 29
The orbitofrontal cortex in methamphetamine addiction: involvement in fear
Goldstein, R. Z., Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Depue, R. A., & Gur, R. C. (2002) · NeuroReport · doi:10.1097/00001756-200212030-00017 · Cited by 29
Self-citationHeidbreder, C. A. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0803-6 · Cited by 30
Czermak, C., Lehofer, M., Wagner, E. M., Prietl, B., Lemonis, L., Rohrhofer, A., Schauenstein, K., & Liebmann, P. M. (2004) · Addiction · doi:10.1111/j.1360-0443.2003.00621.x · Cited by 31
Cocaine, Hormones, and Behavior
Mello, N. K., & Mendelson, J. H. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50106-2 · Cited by 30
Brain PET Imaging in Obesity and Food Addiction: Current Evidence and Hypothesis
Iozzo, P., Guiducci, L., Guzzardi, M. A., & Pagotto, U. (2012) · Obesity Facts · doi:10.1159/000338328 · Cited by 27
Bickel, W. K., Lemos, R. F., Myslowski, J., Quddos, F., Fontes, R. M., Barbosa-França, B., Faubion-Trejo, R., & LaConte, S. M. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00498-z · Cited by 30
Gould, R. W., Gage, H. D., Banks, M. L., Blaylock, B. L., Czoty, P. W., & Nader, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.007 · Cited by 28
Predictors of sustained abstinence during psychosocial treatments for cocaine dependence
Crits-Christoph, P. F., Gibbons, M. B. C., Barber, J. P., Hu, B., Hearon, B. A., Worley, M., & Gallop, R. (2007) · Psychotherapy Research · doi:10.1080/10503300600818210 · Cited by 34
Thanos, P. K., Kim, R., Cho, J. A., Michaelides, M., Anderson, B. J., Primeaux, S. D., Bray, G. A., Wang, G., Robinson, J. K., & Volkow, N. D. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.08.011 · Cited by 29
Self-citationBlum, K., Chen, T. J. H., Downs, B. W., Meshkin, B., Blum, S. H., Pons, M. M., Mengucci, J. F., Waite, R. L., Arcuri, V., ., M. V., et al. (2007) · Trends in Applied Sciences Research · doi:10.3923/tasr.2007.132.138 · Cited by 31
Brain Imaging in Nonhuman Primates: Insights into Drug Addiction
Nader, M. A., & Czoty, P. W. (2008) · ILAR Journal · doi:10.1093/ilar.49.1.89 · Cited by 29
Functional imaging and neurochemical correlates of stimulant self-administration in primates
Howell, L. L., & Wilcox, K. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1207-y · Cited by 27
Insights from recent positron emission tomographic studies of drug abuse and dependence
Chang, L., & Haning, W. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218594.46431.2f · Cited by 27
Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators
Mukhara, D., Banks, M. L., & Neigh, G. N. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00309 · Cited by 26
Moeller, F. G., Steinberg, J. L., Lane, S. D., Kjome, K. L., Ma, L., Ferré, S., Schmitz, J. M., Green, C. E., Bandak, S. I., Renshaw, P. F., et al. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00044 · Cited by 28
Use of stimulants to treat cocaine and methamphetamine abuse
Moeller, F. G., Schmitz, J. M., Herin, D. V., & Kjome, K. L. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0062-x · Cited by 26
Cocaine use and the mid-latency auditory evoked responses
Boutros, N. N., Campbell, D., Petrakis, I. L., Krystal, J. H., Caporale, M., & Kosten, T. R. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00207-9 · Cited by 26
Sleep-mediated regulation of reward circuits: implications in substance use disorders
Guo, R., Vaughan, D. T., Rojo, A. L. A., & Huang, Y. H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01356-8 · Cited by 25
Hill, S. Y., Lichenstein, S. D., Wang, S., Carter, H., & McDermott, M. (2013) · Advances in Molecular Imaging · doi:10.4236/ami.2013.34007 · Cited by 26
Sex differences in neurocognitive functioning among abstinent recreational cocaine users
Rahman, Q., & Clarke, C. D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2257-8 · Cited by 32
Understanding and Treating Opioid Addiction in a Patient With Cancer Pain
Kircher, S. M., Zacny, J. P., Apfelbaum, S. M., Passik, S. D., Kirsch, K., Burbage, M., & Lofwall, M. R. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.07.006 · Cited by 26
Grasing, K., & Ghosh, S. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00093-8 · Cited by 25
Asociación entre adicción a la comida y estado nutricional en universitarios chilenos
Obregón, A. M., Fuentes-Fuentes, J., & Pettinelli, P. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015000500006 · Cited by 33
Metadata
- Authors
- Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P.
- Affiliations
- State University of New York (US)
- Brookhaven National Laboratory (US)
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1993-06
- Volume
- 14
- Issue
- 2
- Pages
- 169-177
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1997829966
- Cited by
- 924
- References
- 76
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 21 · 2023: 21 · 2022: 20 · 2021: 16 · 2020: 28 · 2019: 29 · 2018: 40 · 2017: 31 · 2016: 37 · 2015: 46 · 2014: 39 · 2013: 61 · 2012: 59
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Synapse (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- National Institute of Environmental Research
- National Institutes of Health (5p01ns015638-15)
- National Institute on Drug Abuse (DA 06 891-02)
- National Institute of Neurological Disorders and Stroke (NS15638)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- cocaine dependence, orbitofrontal cortex, cingulate cortex, cocaine self-administration, dopaminergic dysfunction, compulsive drug taking, detoxification
- MeSH terms
- Adult, Brain, Cocaine, Deoxyglucose, Frontal Lobe, Glucose, Humans, Male, Reference Values, Spiperone, Tomography, Emission-Computed, Dopamine Agents, Receptors, Dopamine D2, Fluorodeoxyglucose F18, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.